Home - Products - Others - Other Targets - Epidermal Growth Factor Receptor Peptide (985-996)

Epidermal Growth Factor Receptor Peptide (985-996)

CAS No. 96249-43-3

Epidermal Growth Factor Receptor Peptide (985-996)( ——— )

Catalog No. M41544 CAS No. 96249-43-3

Epidermal Growth Factor Receptor Peptide (985-996) is an amino acid peptide fragment derived from positions 985-996 in epidermal growth factor receptor (EGFR).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Epidermal Growth Factor Receptor Peptide (985-996)
  • Note
    Research use only, not for human use.
  • Brief Description
    Epidermal Growth Factor Receptor Peptide (985-996) is an amino acid peptide fragment derived from positions 985-996 in epidermal growth factor receptor (EGFR).
  • Description
    Epidermal Growth Factor Receptor Peptide (985-996) is an amino acid peptide fragment derived from positions 985-996 in epidermal growth factor receptor (EGFR).
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    96249-43-3
  • Formula Weight
    1376.49
  • Molecular Formula
    C61H93N13O23
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kris RM, et al. Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein. Cell. 1985 Mar;40(3):619-25.?
molnova catalog
related products
  • TDRL-551

    TDRL-551 is a novel and potent replication protein A (RPA) inhibitor (IC50=18 μM) with potential anticancer activity.

  • ML221

    ML221 is a potent?apelin /APJ?functional antagonist, inhibiting apelin-13-mediated activation of APJ, with?IC50s of 0.70 μM in the cAMP assay, and 1.75 μM in the β-arrestin assay, and?EC80?of 10 nM in both assays.

  • RBN013209

    RBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.